17-20 SEPTEMBER 2023 | VALENCIA
Influenza
RSV Disease
Covid-19
#ESWI2023 • A Medscape LIVE Event • 17 September 13:15 – 14:45 CEST

The high burden of RSV and influenza: Beyond the acute infection in adults - Satellite Symposium organised by Medscape

TARGET AUDIENCE

This activity is intended for an international audience of non-US primary care physicians, pulmonologists, cardiologists, endocrinologists, and infectious disease specialists.

LEARNING OBJECTIVES

Upon completion of this activity, participants will:

Have increased knowledge regarding the

  • Burden of respiratory syncytial virus (RSV) and influenza infections across the spectrum of disease in adults
  • Long-term sequelae of RSV and influenza in adults
  • Unmet needs in the management (including diagnosis) of RSV in adults
  • Latest advances in RSV and influenza vaccine development

Demonstrate greater confidence in their ability to

  • Identify who is at risk of chronic complications of RSV and influenza
ACCREDITATION STATEMENT

The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 1.5 continuing professional development credits (CPD).

Stream the session now:

Timing

Sunday 17 September 2023, 13:15 - 14:45 CEST

Chair
Peter Openshaw
BIO
Peter Openshaw
ESWI Board member, Imperial College, United Kingdom
Session information
Introduction
Peter Openshaw, Professor of Experimental Medicine Imperial College London, United Kingdom

It Could Be You: The Unheard Voices of RSV and Influenza From a Specialist Perspective
Panel discussion with Marco Goeijenbier, Krzysztof Narkiewicz and David B Price

Potential economic benefit of RSV prevention in Europe
Maarten Postma, University of Groningen, Netherlands

RSV Vaccines: what's in the pipeline?
Joanne Wildenbeest, UMC Utrecht, Netherlands